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1. Introduction {#efs25339-sec-0002}
===============

1.1. Background and Terms of Reference {#efs25339-sec-0003}
--------------------------------------

Regulation (EC) No 1831/2003[1](#efs25339-note-1007){ref-type="fn"} establishes the rules governing the Community authorisation of additives for use in animal nutrition. In particular, Article 14(1) of that Regulation lays down that an application for renewal shall be sent to the Commission at the latest one year before the expiry date of the authorisation.

The European Commission received four requests from Lesaffre Feed Additives[2](#efs25339-note-1008){ref-type="fn"} for renewal of the authorisations of the product Actisaf^®^ Sc47 (*Saccharomyces cerevisiae* CNCM I‐4407), when used as a feed additive for lambs for fattening, dairy goats, dairy sheep, dairy buffaloes, pigs for fattening (category: zootechnical additive; functional group: gut flora stabiliser) and horses (category: zootechnical additive; functional group: digestibility enhancer).

According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the applications to the European Food Safety Authority (EFSA) under Article 14(1) (renewal of an authorised feed additive). EFSA received directly from the applicant four technical dossiers in support of these applications. The particulars and documents in support of the applications were considered valid by EFSA as of 11 April 2016 (lambs for fattening), 1 June 2016 (minor dairy ruminants and horses) and 1 June 2017 (pigs for fattening).

According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and documents submitted by the applicant, shall undertake an assessment in order to determine whether the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of the product Actisaf^®^ Sc47 (*Saccharomyces cerevisiae* CNCM I‐4407), when used under the proposed conditions of use (see Section [3.1.4](#efs25339-sec-0014){ref-type="sec"}).

1.2. Interpretation of the Terms of Reference {#efs25339-sec-0004}
---------------------------------------------

The applications for renewal of the authorisations do not include a proposal for amending or supplementing the conditions of the original authorisations that would have an impact on the efficacy of the additive; therefore efficacy is not assessed. The present opinion will focus only on the safety aspects.

1.3. Additional information {#efs25339-sec-0005}
---------------------------

The additive Actisaf^®^ Sc47[3](#efs25339-note-1009){ref-type="fn"} is a preparation of *Saccharomyces cerevisiae* CNCM I‐4407.[4](#efs25339-note-1010){ref-type="fn"} The Scientific Committee on Animal Nutrition (SCAN) issued an opinion on the safety of this product for piglets, sows, beef and dairy cattle, including the safety for the user, the consumer and the environment (European Commission, [1997](#efs25339-bib-0014){ref-type="ref"}/2003), and another on the efficacy for cattle for fattening (European Commission, [2002](#efs25339-bib-0015){ref-type="ref"}). EFSA issued several opinions on the safety and efficacy of this product for the following species: lambs for fattening (EFSA, [2006a](#efs25339-bib-0001){ref-type="ref"}), dairy small ruminants (EFSA, [2006b](#efs25339-bib-0002){ref-type="ref"}), horses (EFSA, [2006c](#efs25339-bib-0901){ref-type="ref"}), calves for rearing (EFSA, [2007a](#efs25339-bib-0003){ref-type="ref"}), pigs for fattening (EFSA, [2007b](#efs25339-bib-0004){ref-type="ref"}), dairy buffaloes (EFSA, [2008](#efs25339-bib-0006){ref-type="ref"}), calves for rearing (EFSA, [2010](#efs25339-bib-0007){ref-type="ref"}) and rabbits for fattening and non food‐producing rabbits (EFSA FEEDAP Panel, [2012a](#efs25339-bib-0010){ref-type="ref"}).

The product is already authorised for use in cattle for fattening,[5](#efs25339-note-1011){ref-type="fn"} sows,[6](#efs25339-note-1012){ref-type="fn"} piglets,[7](#efs25339-note-1013){ref-type="fn"} dairy cows,[8](#efs25339-note-1014){ref-type="fn"} lambs for fattening,[9](#efs25339-note-1015){ref-type="fn"} dairy goats, dairy sheep,[10](#efs25339-note-1016){ref-type="fn"} horses,[11](#efs25339-note-1017){ref-type="fn"} pigs for fattening,[12](#efs25339-note-1018){ref-type="fn"} dairy buffaloes,[13](#efs25339-note-1019){ref-type="fn"} calves for rearing,[14](#efs25339-note-1020){ref-type="fn"} rabbits for fattening and non‐food producing rabbits.[15](#efs25339-note-1021){ref-type="fn"}

2. Data and methodologies {#efs25339-sec-0006}
=========================

2.1. Data {#efs25339-sec-0007}
---------

The present assessment is based on data submitted by the applicant in the form of four technical dossiers[16](#efs25339-note-1022){ref-type="fn"} in support of the request for the renewal of the authorisation for the use of Actisaf^®^ Sc47 (*Saccharomyces cerevisiae* CNCM I‐4407) as a feed additive. The technical dossiers were prepared following the provisions of Article 14 of Regulation (EC) No 1831/2003 and the applicable EFSA guidance documents.

The FEEDAP Panel used the data provided by the applicant together with data from other sources, such as previous risk assessments by EFSA, to deliver the present output.

The European Union Reference Laboratory (EURL) considered that the conclusions and recommendations reached in the previous assessments are valid and applicable for the current applications.[17](#efs25339-note-1023){ref-type="fn"}

2.2. Methodologies {#efs25339-sec-0008}
------------------

The approach followed by the FEEDAP Panel to assess the safety and the efficacy of Actisaf^®^ Sc47 (*Saccharomyces cerevisiae* CNCM I‐4407) is in line with the principles laid down in Regulation (EC) No 1829/2003 and the relevant guidance documents: Guidance on the renewal of the authorisation of feed additives (EFSA FEEDAP Panel, [2013](#efs25339-bib-0013){ref-type="ref"}), Guidance on zootechnical additives (EFSA FEEDAP Panel, [2012b](#efs25339-bib-0011){ref-type="ref"}) and Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, [2012c](#efs25339-bib-0012){ref-type="ref"}).

3. Assessment {#efs25339-sec-0009}
=============

The additive Actisaf^®^ Sc47 is a preparation consisting of dried cells of *S. cerevisiae* (CNCM I‐4407) with no carriers, intended for use as a zootechnical additive in feed for lambs for fattening, dairy goats, dairy sheep, dairy buffaloes, pigs for fattening (gut flora stabiliser), and horses (digestibility enhancer). It is authorised at a minimum content of 1.4 × 10^9^ CFU/Kg of complete feed for lambs for fattening, 7 × 10^8^ CFU/Kg of complete feed for dairy goats and dairy sheep, 5 × 10^8^ CFU/Kg of complete feed for dairy buffaloes, 8 × 10^8^ CFU/kg of complete feed for horses and 1.25 × 10^9^ CFU/Kg of complete feed for pigs for fattening. The additive is authorised with no maximum content.

3.1. Characterisation {#efs25339-sec-0010}
---------------------

### 3.1.1. Characterisation of the active agent {#efs25339-sec-0011}

The *S. cerevisiae* strain of unknown origin is deposited at the Collection Nationale de Cultures de Microorganismes (CNCM, France) with the accession number CNCM I‐4407.[18](#efs25339-note-1024){ref-type="fn"} It has not been genetically modified.

Identification at the species level was achieved by sequence analysis of the D1/D2 region of the 26S rRNA gene.[19](#efs25339-note-1025){ref-type="fn"} Strain level identification was based on Delta‐polymerase chain reaction (PCR).[20](#efs25339-note-1026){ref-type="fn"} Genetic stability was confirmed by pulse‐field gel electrophoresis of three colonies obtained from cultures produced in 1990, 1999 and 2000, and by comparison of the Delta‐PCR profiles of culture samples produced in 1999 and 2010.

### 3.1.2. Characterisation of the additive {#efs25339-sec-0012}

The product is marketed in three forms: Actisaf^®^ Sc47 standard, Actisaf^®^ Sc47 powder and Actisaf^®^ Sc47 HR. All of them were authorised with a declared minimum concentration of viable yeast cells in the additive of 5 × 10^9^ CFU/g. ■■■■■

The applicant declared that additive has not been modified since the last authorisation and provided data from recent batches on the composition and purity. Compliance with specifications was confirmed by analysis of nine batches from 2015 (three of each form) (mean value of 1.0 × 10^10^ CFU/g, range = 0.8 -- 1.1 × 10^10^ CFU/g, coefficient of variation CV = 11%).[21](#efs25339-note-1027){ref-type="fn"}

The same batches were analysed for microbial contaminants. Results confirm compliance with limit levels (mesophilic bacteria \< 10^6^ CFU/g, total coliforms \< 100 CFU/g, *Escherichia coli* \< 10 CFU/g, *Staphylococcus aureus* absence in 1 g and *Salmonella* absence in 25 g). Compliance was further confirmed in three batches produced in 2016 (two of the standard form and one of the powder form).[22](#efs25339-note-1028){ref-type="fn"}

Five batches (three of the standard form and one of each of the others) produced in 2016 were analysed for chemical contaminants. Results confirm compliance with limit levels for heavy metals (cadmium \< 1 mg/kg, mercury \< 0.1 mg/kg, lead \< 5 mg/kg), arsenic (\< 2 mg/kg), fluorine (\< 150 mg/kg) and aflatoxin B1 (\< 1 μg/kg).[23](#efs25339-note-1029){ref-type="fn"}

### 3.1.3. Stability and homogeneity {#efs25339-sec-0013}

Shelf life and stability of each form of the additive, and its capacity to be uniformly distributed in premixtures and feed for the target species were addressed in a previous opinion (EFSA FEEDAP Panel [2012a](#efs25339-bib-0010){ref-type="ref"}). The applicant provided new data on stability of the product in premixtures[24](#efs25339-note-1030){ref-type="fn"} and feedingstuffs[25](#efs25339-note-1031){ref-type="fn"} which supported previous conclusions.

### 3.1.4. Conditions of use {#efs25339-sec-0014}

Actisaf^®^ Sc47 is currently authorised at the minimum dose of: 1.4 × 10^9^ CFU/kg of complete feed for lambs for fattening,7 × 10^8^ CFU/Kg of complete feed for dairy goats and dairy sheep,5 × 10^8^ CFU/Kg of complete feed for dairy buffaloes,8 × 10^8^ CFU/kg of complete feed for horses and1.25 × 10^9^ CFU/kg of complete feed for pigs for fattening.

The applicant proposes to maintain the same conditions of use.

3.2. Safety {#efs25339-sec-0015}
-----------

The species *S. cerevisiae* is considered by EFSA to be suitable for the qualified presumption of safety (QPS) approach to establishing safety for the target species, consumers and the environment (EFSA, [2007c](#efs25339-bib-0005){ref-type="ref"}; EFSA BIOHAZ Panel, [2017](#efs25339-bib-0009){ref-type="ref"}). This approach requires the identity of the active agent to be established. In the view of the FEEDAP Panel, the identity of the strain *S. cerevisiae* (CNCM I‐4407) was confirmed by sequence analysis of the 26S rRNA gene in the present assessment. Accordingly, this strain is considered by EFSA to be suitable for the QPS approach to safety and is presumed safe for the target species, consumers of products from animals fed the additive and the environment.

In a previous opinion (EFSA FEEDAP Panel, [2012a](#efs25339-bib-0010){ref-type="ref"}), Actisaf^®^ Sc47 STD was found not to be a skin irritant. The FEEDAP Panel considered that the conclusion could be extrapolated to the other two forms of the additive. In the same opinion, the Panel concluded that given the absence of particles of inhalable size and the virtual absence of dust, exposure and therefore, toxicity and sensitisation via a respiratory route is not to be expected.

A new eye irritation study according to OECD 405 of Actisaf^®^ Sc47 STD has been provided.[26](#efs25339-note-1032){ref-type="fn"} Results showed slight redness and corneal opacity, reversible after 2 days. Therefore, the test item is considered non‐irritant to the eyes. The result on the standard formulation can be extrapolated to the other formulations.

The applicant provided a certificate from the production plant medical doctors stating that no allergic reactions have occurred in workers[27](#efs25339-note-1033){ref-type="fn"} and a summary record of users complaints from 2006, where no complaint on the safety of the product is observed.[28](#efs25339-note-1034){ref-type="fn"}

The applicant also performed a literature search on the safety of *S. cerevisiae* [29](#efs25339-note-1035){ref-type="fn"} using the following databases: BIOSIS Toxicology, CAB Abstracts, Current Contents, Embase, FSTA, Global Health, MEDLINE, RTECS and ToxFile. The search covered the period 2007‐2016 and the search terms included *Saccharomyces cerevisiae*, and different sets of keywords relating to toxicity, cytotoxicity, genotoxicity, allergenicity, sensitisation and pathogenicity for humans and animals. The search did not reveal other publications than reports of occasional infections on immune suppressed patients (Annex [A](#efs25339-sec-1001){ref-type="sec"}), which are well known and unrelated to the additive under assessment.

Therefore, the FEEDAP Panel concludes that there is no new evidence that would lead it to reconsider previous conclusions that Actisaf^®^ Sc47 is safe for the target species, consumers, users/workers and the environment under the authorised conditions of use.

3.3. Post‐market monitoring {#efs25339-sec-0016}
---------------------------

The FEEDAP Panel considers that there is no need for specific requirements for a post‐market monitoring plan other than those established in the Feed Hygiene Regulation[30](#efs25339-note-1036){ref-type="fn"} and Good Manufacturing Practice.

4. Conclusions {#efs25339-sec-0017}
==============

The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation.

In previous opinions, Actisaf^®^ Sc47 was presumed safe for the target species, consumers of products from animals fed the additive and the environment. Additionally, it was found not to be a skin or eye irritant.

No new evidence has been found that would make the panel reconsider the previous conclusions on the safety of the additive. Therefore, the Panel considers that the additive Actisaf^®^ Sc47 remains safe under the approved conditions for lambs for fattening, minor dairy ruminants, horses and pigs for fattening, the consumer, user and the environment.

Documentation provided to EFSA {#efs25339-sec-0018}
==============================

Actisaf Sc47 for lambs for fattening. April 2016. Submitted by Lesaffre Feed Additives.Actisaf Sc47 lambs for fattening. Supplementary information. October 2016. Submitted by Lesaffre Feed Additives.Actisaf Sc47 lambs for fattening. Supplementary information. July 2017. Submitted by Lesaffre Feed Additives.Actisaf Sc47 for minor dairy ruminants. June 2016. Submitted by Lesaffre Feed Additives.Actisaf Sc47 for minor dairy ruminants. Supplementary information. July 2017. Submitted by Lesaffre Feed Additives.Actisaf Sc47 for horses. June 2016. Submitted by Lesaffre Feed Additives.Actisaf Sc47 for horses. Supplementary information. July 2017. Submitted by Lesaffre Feed Additives.Actisaf Sc47 for pigs for fattening. March 2017. Submitted by Lesaffre Feed Additives.Comments from Member States.
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